HDAC (Histone Deacetylase), otherwise known as a histone deacetylase, is an important type of enzyme involved in the process of histone modifications.

This article summarized the latest R&D progress of Entrectinib, the Mechanism of Action for Entrectinib, and the drug target R&D trends for Entrectinib.

Coeptis Therapeutics delivers an update on the safety and dosage from Phase 1 Trials of DVX201, intended for those with Relapsed/Refractory AML or High Risk MDS.

This article summarized the latest R&D progress of Daprodustat, the Mechanism of Action for Daprodustat, and the drug target R&D trends for Daprodustat.

GnRHR, or Gonadotropin-Releasing Hormone Receptor, plays a crucial role in the human body's reproductive system.

This article summarized the latest R&D progress of Colecalciferol, the Mechanism of Action for Colecalciferol, and the drug target R&D trends for Colecalciferol.

Alzheon, Inc. reported that their Phase 2 study of ALZ-801 resulted in reduced neural degradation, stabilized brain function, and improved cognition in initial Alzheimer's patients with the apolipoprotein ε4 allele over two years of treatment.

This article summarized the latest R&D progress of Camptothecin, the Mechanism of Action for Camptothecin, and the drug target R&D trends for Camptothecin.

To acquire patent data related to a delineated antibody sequence, the Patsnap Bio Sequence Database is an optimal resource for conducting a systematic search.

This article summarized the latest R&D progress of Baicalin, the Mechanism of Action for Baicalin, and the drug target R&D trends for Baicalin.

IQ32 Bio and Horizon Therapeutics initiated a Phase 2 trial for bempikibart's effectiveness against severe adult alopecia areata.

This article summarized the latest R&D progress of Artesunate, the Mechanism of Action for Artesunate, and the drug target R&D trends for Artesunate.